News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Pharmaceutical Commerce - March 2019

Improving medication adherence with technology

ByBy Suzanne Shelley, Contributing Editor
March 18th 2019

The longstanding adherence problem is yielding to new technology

The outcomes-based reimbursement environment

ByBY TARA HERINGTON, CARDINAL HEALTH SONEXUS™
March 17th 2019

A changing role for hubs in collecting critical data, raising adherence

Uplifting the patient care continuum

ByBy Nick Basta
March 14th 2019

Healthcare and drug policy take center stage in Washington

By
March 6th 2019

Presidential campaigns only magnify an already intense debate

Patient support / hub services continue to evolve

ByNicholas Basta
March 5th 2019

The goal of producing meaningful data is driving industry progress

Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies

2

The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection

3

Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies

4

Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial

5

Trade & Channel Strategies 2025: DSCSA Status Following Implementation

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us